The treatment of acute myeloid leukaemia

Open Access

1 January 1974

journal article
research article
Published by BMJ in Journal of Clinical Pathology

Vol. 27 (1) , 53-54
https://doi.org/10.1136/jcp.27.1.53

Abstract

The use of a combination of daunorubicin and cytosine arabinoside in the treatment of acute myeloid leukaemia in a district general hospital is described. The results in a series of 30 cases are considered.

Keywords

TREATMENT
HOSPITAL
ARABINOSIDE
CYTOSINE
DAUNORUBICIN
ACUTE MYELOID
MYELOID LEUKAEMIA
LEUKAEMIA THE USE

This publication has 3 references indexed in Scilit:

Management of Adult Acute Myelogenous Leukaemia
BMJ, 1973
Combination Chemotherapy using L-Asparaginase, Daunorubicin, and Cytosine Arabinoside in Adults with Acute Myelogenous Leukaemia
BMJ, 1970
[Trial of treatment of acute lymphoblastic and myeloblastic leukemias by a new antibiotic: rubidomycin (RP 13,057). Study of 61 cases].
1967